Latest From Biotech Now

Innovation Act Passed By House

House

The Innovation Act (H.R. 3309), which is intended to reduce frivolous patent-related litigation, was passed by the House today. As we’ve noted, BIO does not support the bill in its current form, which would ultimately undermine biotech research and innovation by making it more difficult for patent holders with legitimate claims to protect their intellectual property. A number of Representatives offered amendments to the bill, several of which BIO supported. These amendments address serious shortcomings with the bill, Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Kick-Off Planning for San Diego Convention

mayor115x76

The BIO 2014 International Convention in San Diego is just around the corner. With that in mind, we kicked planning efforts into high gear the week before Thanksgiving. The week started with a press conference featuring Interim Mayor Todd Gloria, BIO International Convention President Scott Whitaker, Convention Center President Carol Wallace, and Biocom President and CEO Joe Panetta. After that, productive meetings were held with the convention Steering, Program and Host Committees, as well as Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Biotech Stocks Hit Record Highs…Again

BIOtech-stocks

Biotech stocks hit an all-time high this week, driven by strong performance among large cap sector leaders with strong product portfolios. A common benchmark for the sector, the NASDAQ Biotechnology Index (NBI) has outperformed the S&P 500 by a factor of over 2X. The NBI is up 61% year to date, compared with 26% for the S&P 500. We’ll be discussing this strong performance in New York this February at the BIO CEO & Investor Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , ,

NYC Launches $100M Life Science Fund

On Tuesday, Deputy Mayor Robert Steel announced that the city is launching the New York City Emerging Life Science Technology Investment Fund, a $100 million venture fund for life sciences research. New York City will invest $10 million along with $40 million from Eli Lilly, Celgene and GE Ventures, with the remaining $50 million matched by venture capital partnerships. The fund will be used to invest in 15-20 early-stage research and development companies by 2020. Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , ,

Canada Surpasses the US in the Approval of AquaBounty GM Salmon Eggs

1278946009098-e1386174723242 copy

In its recent article titled, AquaBounty GM Salmon Eggs Cleared for Production in Canada, The Fish Site, highlights a much needed success story in the field of animal biotechnology, “Environment Canada, the agency of the Government of Canada with responsibility for regulating environmental policies and issues, has decided that Genetically Modified (GM) AquAdvantage® Salmon from AquaBounty Technologies is not harmful to the environment or human health when produced in contained facilities. “AquaBounty will therefore now Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , ,